Official recall notice

FDA DrugClass IINotable

Zoladex implant Recall (Oct 2026) – TerSera Therapeutics

Product: Zoladex (goserelin) implant, 3.6 mg, One single-Use Syringe packaged in a carton, Rx only, Manufactured for: TerSera therapeutics LLC, Deerfield, IL 60015, BY: AstraZeneca UK Limited, Macclesfield, England, Product of Switzerland, website at www.zoladex.com, NDC 70720-950-36.

Recall date
2026-10-07
Category
Drug
FDA class
Class II

Why it was recalled

Hazard

Temperature Abuse: Product sat in a non-temperature-controlled FedEx trailer at ambient outdoor conditions for 25.5 hours.

One email a week when there are new recalls. Confirm by email; unsubscribe anytime.

Product description

Temperature Abuse: Product sat in a non-temperature-controlled FedEx trailer at ambient outdoor conditions for 25.5 hours.

Affected products

Lot#: YN0099, Exp 01/31/2028

Verify with the official notice →
Share:

Related Recalls

2026-10-14 · FDA_DRUG
FDA Recall: Par Health and Endo USA: Argatroban Injection 250 mg/2.5 mL (100 mg/mL)
Par Health and Endo USA
2026-10-09 · FDA_DRUG
FDA Recall: Par Pharmaceutical: Brevital Sodium 500 mg/vial for Injection
Par Pharmaceutical
2026-10-07 · FDA_DRUG
FDA Recall: Paroxetine Extended-Release Tablets, 37.5mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc.,
Apotex Corp.
2026-10-07 · FDA_DRUG
FDA Recall: FOCUS PI Hypromellose 0.7% Formula, 0.3 FL O (10 mL) per vial, STERILE, Manufactured for: Covalent M
Aurolab Trust